MIR503HG impeded ovarian cancer progression by interacting with SPI1 and preventing TMEFF1 transcription

Jun Tian1, Lei Yang2, Zhongtai Wang3

  • 1Department Gynecology, HuaiHe Hospital of HeNan University, Kaifeng, HeNan, China.

Aging
|June 30, 2022
PubMed

Insights

MIR503 host gene (MIR503HG) suppresses ovarian cancer progression by inhibiting SPI1-mediated TMEFF1 activation. Overexpression of MIR503HG reduces proliferation and invasion, while its silencing promotes these malignant behaviors.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The MIR503 host gene (MIR503HG) is recognized as a tumor suppressor in various human cancers.
  • Its specific function and regulatory mechanisms in ovarian cancer remain incompletely understood.

Purpose of the Study:

  • To investigate the role of MIR503HG in ovarian cancer.
  • To elucidate the molecular mechanisms underlying MIR503HG's function in ovarian cancer.

Main Methods:

  • Quantitative real-time PCR to assess MIR503HG expression levels.
  • Cell proliferation, invasion, apoptosis, and EMT assays to evaluate MIR503HG function.
  • RNA immunoprecipitation, RNA pull-down, dual luciferase reporter, and Chromatin immunoprecipitation assays to determine molecular interactions.
  • Western blotting to analyze pathway activation.
  • In vivo tumorigenesis assays in nude mice.

Main Results:

  • MIR503HG expression was significantly lower in ovarian tumor tissues and cells compared to normal controls.
  • MIR503HG overexpression inhibited ovarian cancer cell proliferation, invasion, and epithelial-mesenchymal transition (EMT), while promoting apoptosis.
  • MIR503HG directly binds to transcription factor SPI1, inhibiting SPI1-mediated transcriptional activation of TMEFF1.
  • MIR503HG knockdown led to increased TMEFF1 expression, activating MAPK and PI3K/AKT pathways.
  • MIR503HG overexpression suppressed tumor growth in vivo.

Conclusions:

  • MIR503HG functions as a tumor suppressor long non-coding RNA (lncRNA) in ovarian cancer.
  • MIR503HG exerts its tumor-suppressive effects by inhibiting the SPI1-TMEFF1 axis.
  • MIR503HG represents a potential therapeutic target for ovarian cancer treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Gene Regulation During Sporulation01:17

Gene Regulation During Sporulation

Sporulation is a complex developmental process that allows certain Gram-positive bacteria, such as Bacillus subtilis and Clostridium species, to survive extreme environmental conditions. This process is tightly regulated by a series of signaling cascades and transcriptional controls, ensuring the formation of a highly resistant endospore.Sporulation is triggered by unfavorable conditions, such as nutrient depletion, and is governed by a phosphorelay system. One of the sensor kinases, such as...
77
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K